support@goodrxmedicine.com
Store Phone Numbers 
Telegram
Brilinta 90 Mg Tablet
Brilinta 90 Mg Tablet
50 orders placed last week
Trusted Source-
Primary treatment for Acute Coronary Syndrome (ACS)
-
FDA-approved active ingredient Ticagrelor
-
Reduces stent thrombosis
-
Starts acting within 30 minutes
-
Fast shipping for your convenience
Medically Reviewed by Dr. Akansha Kaushal
Written by Julian Carter
What is Brilinta 90 mg
Brilinta 90 mg is an antiplatelet medication manufactured by AstraZeneca in accordance with WHO guidelines in a GMP-compliant facility. It contains Ticagrelor, which helps reduce platelet aggregation to lessen the risk of heart-related events in individuals with Acute Coronary Syndrome (ACS).
The Brilinta 90 mg composition supports Stroke prevention and protection against Stent Thrombosis. As an FDA-approved treatment, the Brilinta 90 mg tablet is widely used for improving cardiovascular outcomes in high-risk individuals.
Uses of Brilinta 90 mg
Doctors primarily prescribe Brilinta 90 mg tablet to lower the risk of serious heart-related problems, including Heart attack, Stroke, and blood clot formation in high-risk individuals.
Brilinta 90 mg is used for:
- Reducing clot formation in ACS
- Lowering the risk of Myocardial Infarction (MI)
- Supporting Stroke prevention
- Preventing Stent Thrombosis after Angioplasty
- Enhancing protection in Dual Antiplatelet Therapy with Aspirin (ASA)
Working and benefits of Ticagrelor
Brilinta 90 contains Ticagrelor, which is an oral, reversible, direct-acting antagonist of the platelet P2Y12 Adenosine Diphosphate (ADP) receptor. Ticagrelor prevents platelet activation and aggregation by blocking this receptor, which is crucial in the blood clotting process.
By inhibiting signal transduction (cell communication or signal relay inside the cell), it reduces platelet clumping and clot formation, thereby improving blood flow and reducing the risk of cardiovascular events such as Heart attacks and Strokes.
Ticagrelor works immediately without requiring modification by the body and reaches its peak plasma concentration within 1.5 hours, providing a rapid onset of action. Additionally, it increases the levels of a natural substance called Adenosine in the body around blood vessels.
Adenosine helps relax and widen these vessels (vasodilation), allowing better blood flow, and also helps prevent platelets from clumping together (platelet inhibition). Simply put, it helps open blood vessels and stops blood clots from forming, improving circulation.
This mechanism makes Brilinta a potent antiplatelet medication for managing and preventing severe cardiovascular conditions. Therefore, the benefits of Ticagrelor (Brilinta 90 mg) include:
- Effective prevention of blood clot formation post-Acute Coronary Syndrome (ACS)
- Significant reduction in Myocardial Infarction and Stroke risk
- Superior platelet inhibition compared to Clopidogrel (another popular antiplatelet medication)
- Rapid onset and reversible platelet inhibition
- Supports dual antiplatelet therapy with Aspirin for enhanced cardiovascular protection
Dosage and how to take Brilinta 90 mg
Consult a doctor for guidance on the Brilinta 90 mg dosage per day. Here's how to take Brilinta:
- Take Brilinta 90 mg twice daily at the exact times daily for a consistent antiplatelet effect, about 12 hours apart.
- Swallow the tablet whole with water; do not chew or crush it.
- Take with or without food, but try to maintain consistent timing with meals. A light meal can help alleviate stomach discomfort.
- Follow your doctor's instructions carefully, especially if taking Aspirin alongside Brilinta.
Strength and Substitute
GoodRxMedicine has options that vary in active ingredient, price or manufacturer. As a substitute for Brilinta, after consulting your doctor, you may consider other medications that help prevent Stroke or Heart attack, such as:
| Atorlip F 10+145 Mg | $7.80/10 tablets |
| Cipril H 5 + 12.5 mg | $2.40/10 tablets |
| Amlip 5 mg | $1.80/10 tablets |
| Doxacard 2 mg | $2.10/10 tablets |
Side effects
Though Brilinta 90 mg side effects are generally mild, some individuals may experience:
- Headache
- Dizziness
- Nausea
- Diarrhea
- Shortness of breath
- Bleeding or bruising easily
Most antiplatelet medications’ reactions are temporary and improve as the body adjusts. However, individuals should seek medical support if symptoms become severe or persistent.
Interactions
Brilinta can interact with certain medications, medical conditions, and specific foods. Understanding these interactions helps individuals use this antiplatelet medication safely and effectively.
Drug Interactions
Some medicines may alter how Brilinta 90 mg works or intensify Brilinta 90 mg side effects. Major interacting medications include:
- Strong CYP3A4 inhibitors (e.g., Ketoconazole, Clarithromycin)
- CYP3A4 inducers (e.g., Rifampin, Phenytoin)
- Anticoagulants (e.g., Warfarin)
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Other antiplatelet agents (e.g., Clopidogrel)
These combinations may increase the risk of bleeding or reduce the effectiveness of Ticagrelor. Individuals should discuss all medications and supplements with their healthcare provider before starting Brilinta 90 mg therapy to ensure safe management of these interactions.
Being mindful of these interactions supports safer therapy and better treatment outcomes.
Disease Interactions
Certain health conditions require caution when using a Brilinta 90 mg tablet:
- History of bleeding disorders
- Active or recent gastrointestinal bleeding
- Liver impairment
- Asthma or breathing issues
- Recent surgery or trauma
People with these conditions may require an adjusted Brilinta 90 mg dosage per day or alternative therapies.
Food Interactions
Diet can influence the safety and effectiveness of this medicine:
- Alcohol: Combining Brilinta 90 mg and alcohol may increase bleeding tendencies and dizziness.
- Grapefruit products: They may increase ticagrelor levels and worsen adverse reactions.
Precautions
You should carefully follow the precautions for Brilinta to ensure safe use. These safety measures help reduce complications:
- Do not take Brilinta if you are allergic to Ticagrelor or any ingredient in the tablet.
- Inform your doctor if pregnant or breastfeeding.
- Avoid Brilinta if you have active pathological bleeding or a history of Intracranial Hemorrhage (bleeding inside the skull or brain).
- If you have liver impairment, avoid Brilinta or use it only under close supervision.
- Be cautious if you have a history of Asthma or breathing problems, as Brilinta may worsen Dyspnea (breathlessness).
- Inform your doctor about any upcoming surgeries or dental procedures, as you may need to temporarily stop taking Brilinta.
- Limit alcohol consumption; it can increase your risk of bleeding when taking Brilinta.
Why buy from us
When you choose to buy from GoodRxMedicine, you benefit from:
- Exclusive discounts on medications, including Brilinta 90 mg
- Positive customer reviews, ensuring quality and trust
- Dedicated customer support, ready to assist you
- Availability of substitute or alternative medicines
What is Brilinta 90 mg used for?
Brilinta 90 is used to help prevent Heart attack, Stroke, and cardiovascular death in people with Acute Coronary Syndrome (ACS). It works as an antiplatelet medication that reduces platelet aggregation, especially when taken with Aspirin. This helps lower the risk of future cardiac events.
Should Brilinta 90 be taken before or after food?
You can take Brilinta 90 with or without food. It does not matter if you take it on an empty stomach or after a meal. For best results, take Brilinta at the exact times each day, ideally about 12 hours apart, to maintain consistent Ticagrelor levels in the body.
What is the most common side effect of Ticagrelor?
The most common side effect of Ticagrelor is bleeding, including nosebleeds, bruising, or prolonged bleeding from cuts. Shortness of breath (Dyspnea) is also frequently reported. These side effects often improve as the body adjusts to Ticagrelor, but users should consult a doctor if they persist or worsen.
How long should I take Brilinta 90 mg?
Brilinta is typically taken for at least 12 months, although the exact duration may depend on your condition and your doctor's recommendations. People with stents or recent Heart Attacks may need longer therapy to reduce the risk of clot formation and future cardiac events.
Who is the manufacturer of Brilinta?
AstraZeneca Pharmaceuticals manufactures Brilinta. The company produces Brilinta, containing the active ingredient Ticagrelor 90 mg. AstraZeneca develops and supplies this antiplatelet medication to help diminish the risk of heart attacks, Strokes, and stent-related clots.
What is the generic name for Brilinta 90 mg?
The generic name for Brilinta is Ticagrelor. It is an antiplatelet medication used to lower the possibility of Heart attack, Stroke, and cardiovascular death in people with Acute Coronary Syndrome or a previous Heart attack. Ticagrelor works by preventing platelets from clumping and forming blood clots, thereby improving blood flow and protecting the heart.
Is Brilinta 90 mg used for Stroke prevention?
Yes, Brilinta is used for Stroke prevention. It is prescribed to reduce the risk of Stroke in individuals with Acute Ischemic Stroke or high-risk Transient Ischemic Attack (TIA), as well as to prevent recurrent Strokes when used with Aspirin.
